{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:36:04Z","timestamp":1794072964364,"version":"4.8.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Factor VIII (FVIII) functions as a cofactor of FIXa for FX activation in the intrinsic tenase complex. The 1811-1818 region in the FVIII A3 domain was observed to contribute to FIXa binding, and the K1813A\/K1818A mutant increased the binding affinity for FIXa. The current study aims to identify mutated FVIII protein(s) that increase FVIIIa cofactor activity in the 1811-1818 region. FVIII mutants with K1813A, K1818A, and K1813A\/K1818A were expressed in baby hamster kidney cells and were followed by assessments using purified and global coagulation assays for mouse models with hemophilia A (HA). A surface plasmon resonance\u2013based assay revealed that the Kd value of FVIII-K1813A for FIXa interaction was lower than that of the wild-type (WT) (3.9\u00b10.7\/6.3\u00b10.3 nM). However, the Km value of FVIII-K1813A for FIXa on tenase activity was comparable with that of the WT, whereas the kcat of this mutant was significantly greater than that of the WT. Thrombin-catalyzed FVIII-K1813A activation was \u223c1.3-fold more enhanced than that of the WT, and the spontaneous decay of activated FVIII-K1813A was \u223c2.5-fold slower than that of WT. The heat stability assay revealed that the decay rate of FVIII-K1813A was \u223c2.5-fold slower than that of WT. Thrombin generation assay and rotational thromboelastometry using blood samples from patients with HA demonstrated that the addition of FVIII-K1813A (0.5 nM) exhibited a coagulation potential compatible with that of WT (1 nM). In the tail clip assay of HA mice, FVIII-K1813A showed a two- to fourfold higher hemostatic potential than that of the WT. FVIII-K1813A, with higher a FIXa binding affinity, enhances the global coagulation potential because of the stability of FVIII\/FVIIIa molecules.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008187","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:07:38Z","timestamp":1667405258000},"page":"1436-1445","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-2782","authenticated-orcid":false,"given":"Yuto","family":"Nakajima","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Nara Medical University, Kashihara, Japan"},{"name":"2Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9348-9815","authenticated-orcid":false,"given":"Masahiro","family":"Takeyama","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Oda","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0157-5215","authenticated-orcid":false,"given":"Naruto","family":"Shimonishi","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Nara Medical University, Kashihara, Japan"},{"name":"3The Course of Thrombosis and Hemostasis Molecular Pathology, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"issue":"1","key":"2023051316535111900_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","article-title":"Surface-dependent reactions of the vitamin K-dependent enzyme complexes","volume":"76","author":"Mann","year":"1990","journal-title":"Blood"},{"issue":"5992","key":"2023051316535111900_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/312330a0","article-title":"Expression of active human factor VIII from recombinant DNA clones","volume":"312","author":"Wood","year":"1984","journal-title":"Nature"},{"issue":"5992","key":"2023051316535111900_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/312337a0","article-title":"Structure of human factor VIII","volume":"312","author":"Vehar","year":"1984","journal-title":"Nature"},{"issue":"3","key":"2023051316535111900_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0167-4838(86)90208-6","article-title":"The size of human factor VIII heterodimers and the effects produced by thrombin","volume":"871","author":"Fay","year":"1986","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2023051316535111900_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bi00350a035","article-title":"Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity","volume":"25","author":"Eaton","year":"1986","journal-title":"Biochemistry"},{"issue":"24","key":"2023051316535111900_bib6","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1016\/S0021-9258(18)41885-6","article-title":"Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles","volume":"267","author":"Duffy","year":"1992","journal-title":"J\u00a0Biol Chem"},{"issue":"19","key":"2023051316535111900_bib7","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1074\/jbc.271.19.11120","article-title":"Activation of the factor VIIIa-factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine","volume":"271","author":"Gilbert","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"Pt 2","key":"2023051316535111900_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/bj3390217","article-title":"Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity","volume":"339","author":"Kolkman","year":"1999","journal-title":"Biochem J"},{"issue":"41","key":"2023051316535111900_bib9","doi-asserted-by":"crossref","first-page":"25332","DOI":"10.1074\/jbc.271.41.25332","article-title":"Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding","volume":"271","author":"Lenting","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"2023051316535111900_bib10","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1074\/jbc.M804955200","article-title":"The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex","volume":"284","author":"Soeda","year":"2009","journal-title":"J\u00a0Biol Chem"},{"issue":"42","key":"2023051316535111900_bib11","doi-asserted-by":"crossref","first-page":"29826","DOI":"10.1074\/jbc.274.42.29826","article-title":"Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXa","volume":"274","author":"Fay","year":"1999","journal-title":"J\u00a0Biol Chem"},{"issue":"32","key":"2023051316535111900_bib12","doi-asserted-by":"crossref","first-page":"20522","DOI":"10.1016\/S0021-9258(17)32024-0","article-title":"Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site","volume":"269","author":"Fay","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"2023051316535111900_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2001-12-0361","article-title":"Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex","volume":"100","author":"Jenkins","year":"2002","journal-title":"Blood"},{"issue":"21","key":"2023051316535111900_bib14","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1074\/jbc.M113.456467","article-title":"Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa","volume":"288","author":"Griffiths","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"19","key":"2023051316535111900_bib15","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.1016\/S0021-9258(18)42201-6","article-title":"Characterization of the interaction between the A2 subunit and A1\/A3-C1-C2 dimer in human factor VIIIa","volume":"267","author":"Fay","year":"1992","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"2023051316535111900_bib16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/blood.V63.6.1303.1303","article-title":"Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid","volume":"63","author":"Lollar","year":"1984","journal-title":"Blood"},{"issue":"6","key":"2023051316535111900_bib17","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1016\/S0021-9258(19)50585-3","article-title":"Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1\/A3-C1-C2 dimer","volume":"267","author":"Lamphear","year":"1992","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"2023051316535111900_bib18","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.271.11.6027","article-title":"Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis","volume":"271","author":"Fay","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"2023051316535111900_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2014-02-555656","article-title":"Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models","volume":"125","author":"Leong","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2023051316535111900_bib20","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1016\/S0021-9258(17)37260-5","article-title":"Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII","volume":"269","author":"Lenting","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"2023051316535111900_bib21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1074\/jbc.271.4.1935","article-title":"The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX","volume":"271","author":"Lenting","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"36","key":"2023051316535111900_bib22","doi-asserted-by":"crossref","first-page":"26105","DOI":"10.1074\/jbc.M113.500884","article-title":"A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX","volume":"288","author":"Bloem","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"2023051316535111900_bib23","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1074\/jbc.M212053200","article-title":"Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII","volume":"278","author":"Bovenschen","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"2023051316535111900_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood.V97.3.669","article-title":"Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis","volume":"97","author":"Nogami","year":"2001","journal-title":"Blood"},{"issue":"6","key":"2023051316535111900_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH10-12-0777","article-title":"Mechanisms of human neutrophil elastase-catalyzed inactivation of factor VIII(a)","volume":"105","author":"Nogami","year":"2011","journal-title":"Thromb Haemost"},{"issue":"3","key":"2023051316535111900_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2257.2004.00605.x","article-title":"Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference","volume":"26","author":"Okuda","year":"2004","journal-title":"Clin Lab Haematol"},{"issue":"3","key":"2023051316535111900_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jth.15201","article-title":"The C-terminal acidic region in the A1 domain of factor VIII facilitates thrombin-catalyzed activation and cleavage at Arg372","volume":"19","author":"Nakajima","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2023051316535111900_bib28","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1182\/blood-2004-10-3939","article-title":"Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site","volume":"105","author":"Nogami","year":"2005","journal-title":"Blood"},{"key":"2023051316535111900_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0076-6879(93)22010-D","article-title":"Factor VIII and factor VIIIa","volume":"222","author":"Lollar","year":"1993","journal-title":"Methods Enzymol"},{"issue":"1","key":"2023051316535111900_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1160\/TH09-05-0338","article-title":"Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity","volume":"103","author":"Takeyama","year":"2010","journal-title":"Thromb Haemost"},{"issue":"10","key":"2023051316535111900_bib31","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1055\/s-0041-1723996","article-title":"Acidic region residues 1680-1684 in the A3 domain of factor VIII contain a thrombin-interactive site responsible for proteolytic cleavage at Arg1689","volume":"121","author":"Nakajima","year":"2021","journal-title":"Thromb Haemost"},{"issue":"7","key":"2023051316535111900_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/jth.12987","article-title":"Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry","volume":"13","author":"Furukawa","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"24","key":"2023051316535111900_bib33","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi050145o","article-title":"Factor VIII A3 domain residues 1954-1961 represent an A1 domain-interactive site","volume":"44","author":"Ansong","year":"2005","journal-title":"Biochemistry"},{"issue":"24","key":"2023051316535111900_bib34","doi-asserted-by":"crossref","first-page":"16355","DOI":"10.1074\/jbc.M708985200","article-title":"Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V","volume":"283","author":"Gale","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"19","key":"2023051316535111900_bib35","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1016\/S0021-9258(18)98924-6","article-title":"Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog","volume":"266","author":"Lollar","year":"1991","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"2023051316535111900_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood.V57.3.476.476","article-title":"The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombin","volume":"57","author":"Hultin","year":"1981","journal-title":"Blood"},{"issue":"18","key":"2023051316535111900_bib37","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1182\/blood.2020007562","article-title":"Activated protein C has a regulatory role in factor VIII function","volume":"137","author":"Wilhelm","year":"2021","journal-title":"Blood"},{"issue":"21","key":"2023051316535111900_bib38","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2012-10-464164","article-title":"Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype","volume":"121","author":"Siner","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2023051316535111900_bib39","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1074\/jbc.M111.308627","article-title":"Mass spectrometry-assisted study reveals that lysine residues 1967 and 1968 have opposite contribution to stability of activated factor VIII","volume":"287","author":"Bloem","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"2023051316535111900_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.str.2008.03.001","article-title":"Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex","volume":"16","author":"Ngo","year":"2008","journal-title":"Structure"},{"issue":"1","key":"2023051316535111900_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2019000007","article-title":"Gene therapy for hemophilia","volume":"2019","author":"Nathwani","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"2023051316535111900_bib42","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood-2003-10-3591","article-title":"Bioengineering of coagulation factor VIII for improved secretion","volume":"103","author":"Miao","year":"2004","journal-title":"Blood"},{"issue":"17","key":"2023051316535111900_bib43","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","article-title":"X-linked thrombophilia with a mutant factor IX (factor IX Padua)","volume":"361","author":"Simioni","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2023051316535111900_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/hum.2014.106","article-title":"Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial","volume":"26","author":"Monahan","year":"2015","journal-title":"Hum Gene Ther"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/8\/1436\/2051275\/blooda_adv-2022-008187-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/8\/1436\/2051275\/blooda_adv-2022-008187-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T12:54:25Z","timestamp":1683982465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/8\/1436\/486965\/Factor-VIII-mutated-with-Lys1813Ala-within-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,4,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008187","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742392963.793596604","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]}}}